Search Results

You are looking at 1 - 4 of 4 items for

  • Author: Anthony D. Yang x
  • Refine by Access: All x
Clear All Modify Search
Full access

QIM22-196: Participation in a Mentored Cancer Quality Improvement Collaborative Improves QI Aptitude Among Oncology Providers

Rachel Hae-Soo Joung, Brianna Marie D'Orazio, Jeana Springmann, Julie Johnson, Karl Y. Bilimoria, and Anthony D. Yang

Full access

QIM20-129: Are You Ready? Assessing Readiness to Implement Quality Improvement in Hospitals Participating in a Breast Cancer Collaborative

Lindsey Kreutzer, Ashley Byerly, Eileen Ngo, Julie K. Johnson, Karl Y. Bilimoria, and Anthony D. Yang

Full access

QIM20-128: Baseline Assessment of Oncology Providers’ Quality Improvement Knowledge in a Multi-Institutional Breast Cancer Quality Improvement Collaborative

Lindsey Kreutzer, Ashley Byerly, Eileen Ngo, Julie K. Johnson, Karl Y. Bilimoria, and Anthony D. Yang

Full access

NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

Featured Updates to the NCCN Guidelines

Jimmy J. Caudell, Maura L. Gillison, Ellie Maghami, Sharon Spencer, David G. Pfister, Douglas Adkins, Andrew C. Birkeland, David M. Brizel, Paul M. Busse, Anthony J. Cmelak, A. Dimitrios Colevas, David W. Eisele, Thomas Galloway, Jessica L. Geiger, Robert I. Haddad, Wesley L. Hicks Jr, Ying J. Hitchcock, Antonio Jimeno, Debra Leizman, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, James W. Rocco, Cristina P. Rodriguez, Panayiotis S. Savvides, David Schwartz, Jatin P. Shah, David Sher, Maie St. John, Randal S. Weber, Gregory Weinstein, Frank Worden, Justine Yang Bruce, Sue S. Yom, Weining Zhen, Jennifer L. Burns, and Susan D. Darlow

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel’s most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.